Why the study?
The novel extravascular implantable cardioverter-defibrillator has limited pacing capabilities, so alternative strategies must be considered for patients who require permanent stimulation when a transvenous defibrillator is not feasible.
Population
Single patient requiring both defibrillation and pacing while avoiding transvenous implantation
Design
Case report
Answers are grounded in this paper and cite their sources.
Case report reveals successful extravascular defibrillator and epicardial pacemaker co-implantation, highlighting a viable non-transvenous strategy.
The EV-ICD is a novel defibrillator with its lead placed substernally in the anterior mediastinum. Due to limited pacing capabilities, patients requiring permanent stimulation are typically better suited for a transvenous defibrillator. However, in cases where this is not feasible (such as ongoing systemic infection) alternatives must be considered. We present a case where an EV-ICD was combined with an epicardial pacemaker to provide both defibrillation and pacing, while avoiding transvenous implantation.
No takes yet. Share an insight, caveat, or question.
Graup et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: